This includes using environment-responsive and ligand-recognizing nanoparticles to target diseased tissues more effectively.
The focus of CRISPR technology development is on creating specific delivery systems for different diseases. This includes using environment-responsive and ligand-recognizing nanoparticles to target diseased tissues more effectively. Additionally, the use of exosomes and cell membranes from immune cells or diseased organs can help in delivering gene-targeting drugs more efficiently and avoid immune clearance​​.